Tags

Type your tag names separated by a space and hit enter

Polio vaccines: WHO position paper, March 2016-recommendations.
Vaccine. 2017 03 01; 35(9):1197-1199.V

Abstract

This article presents the World Health Organization's (WHO) recommendations on the use of polio vaccine excerpted from the WHO position paper on polio vaccines - March 2016, published in the Weekly Epidemiological Record [1]. This position paper on polio vaccines replaces the 2014 WHO position paper [2]. The position paper summarizes the WHO position on the introduction of at least one dose of inactivated polio vaccine (IPV) into routine immunization schedules as a strategy to mitigate the potential risk of re-emergence of type 2 polio following the withdrawal of Sabin type 2 strains from oral polio vaccine (OPV) [3]. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This position paper reflects the global switch from trivalent to bivalent OPV which took place in April 2016. Recommendations on the use of polio vaccines have been discussed on multiple occasions by SAGE, most recently in October 2016; evidence presented at these meetings can be accessed at: http://www.who.int/immunization/sage/previous/en/index.html.

Authors+Show Affiliations

WHO, Immunization, Vaccines and Biologicals, Avenue Appia 20, 1211 Geneva 27, Switzerland. Electronic address: sageexecsec@who.int.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

27894720

Citation

World Health Organization, . "Polio Vaccines: WHO Position Paper, March 2016-recommendations." Vaccine, vol. 35, no. 9, 2017, pp. 1197-1199.
World Health Organization . Polio vaccines: WHO position paper, March 2016-recommendations. Vaccine. 2017;35(9):1197-1199.
World Health Organization, . (2017). Polio vaccines: WHO position paper, March 2016-recommendations. Vaccine, 35(9), 1197-1199. https://doi.org/10.1016/j.vaccine.2016.11.017
World Health Organization . Polio Vaccines: WHO Position Paper, March 2016-recommendations. Vaccine. 2017 03 1;35(9):1197-1199. PubMed PMID: 27894720.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Polio vaccines: WHO position paper, March 2016-recommendations. A1 - World Health Organization,, Y1 - 2016/11/25/ PY - 2016/11/03/received PY - 2016/11/07/accepted PY - 2016/11/30/pubmed PY - 2017/12/16/medline PY - 2016/11/30/entrez SP - 1197 EP - 1199 JF - Vaccine JO - Vaccine VL - 35 IS - 9 N2 - This article presents the World Health Organization's (WHO) recommendations on the use of polio vaccine excerpted from the WHO position paper on polio vaccines - March 2016, published in the Weekly Epidemiological Record [1]. This position paper on polio vaccines replaces the 2014 WHO position paper [2]. The position paper summarizes the WHO position on the introduction of at least one dose of inactivated polio vaccine (IPV) into routine immunization schedules as a strategy to mitigate the potential risk of re-emergence of type 2 polio following the withdrawal of Sabin type 2 strains from oral polio vaccine (OPV) [3]. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This position paper reflects the global switch from trivalent to bivalent OPV which took place in April 2016. Recommendations on the use of polio vaccines have been discussed on multiple occasions by SAGE, most recently in October 2016; evidence presented at these meetings can be accessed at: http://www.who.int/immunization/sage/previous/en/index.html. SN - 1873-2518 UR - https://www.unboundmedicine.com/medline/citation/27894720/Polio_vaccines:_WHO_position_paper_March_2016_recommendations_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(16)31064-7 DB - PRIME DP - Unbound Medicine ER -